SCM
IDXX icon

Sone Capital Management’s Idexx Laboratories IDXX Stock Holding History

Sone Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,991
Closed -$4.05M – 114
2025
Q4 		$4.05M Sell
5,991
-1,262
-17% -$859K 0.33% 80
2025
Q3 		$4.63M Buy
+7,253
New +$4.4M 0.39% 79
2025
Q2 		– Sell
-25,986
Closed -$10.9M – 113
2025
Q1 		$10.9M Buy
25,986
+11,710
+82% +$5.08M 1.12% 36
2024
Q4 		$5.9M Buy
+14,276
New +$6.26M 0.75% 58

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sone Capital Management's IDXX Position: Q1 2026 in Review

Sone Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 5,991 shares — an estimated $4.05M sold.

Sone Capital Management first reported a position in IDXX in Q4 2024 and held it in 4 quarters. The position peaked at $10.9M in Q1 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Sone Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Sone Capital Management sold 5,991 Idexx Laboratories shares in Q1 2026, an estimated $4.05M.
  • Sone Capital Management first reported a position in Idexx Laboratories in Q4 2024 and held it in 4 quarters.
  • Sone Capital Management's Idexx Laboratories position peaked at $10.9M in Q1 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Sone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.